class name | count |
---|---|
rosids | 19 |
Embryophyta | 4 |
Liliopsida | 4 |
Magnoliophyta | 2 |
Spermatophyta | 1 |
class name | count |
---|---|
Fabaceae | 12 |
Combretaceae | 4 |
Orchidaceae | 4 |
Vitaceae | 2 |
Corsiniaceae | 2 |
Myristicaceae | 2 |
Frullaniaceae | 2 |
Betulaceae | 1 |
Gnetaceae | 1 |
br08003 Category | # of metabolite |
---|---|
Stilbenes | 1 |
br08003 Category | KEGG ID | KNApSAcK ID |
---|---|---|
Stilbenes | C10287 | C00002902 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00002902
![]() |
Pterostilbene
/ 3,5-Dimethoxy-4'-hydroxystilbene |
CHEMBL87712
CHEMBL83527 |
C107773
|
19 / 19 / 20 | 54 / 15 |
![]() |
C00015204
![]() |
Combretastatin A1
/ (Z)-3-Methoxy-6-[2-(3,4,5-trimethoxyphenyl)ethenyl]-1,2-benzenediol |
CHEMBL36255
CHEMBL520204 |
C063690
|
5 / 0 / 0 |
![]() |
|
C00015303
![]() |
3,4',6-Trimethoxystilbene
|
CHEMBL2043271
|
![]() |
|||
C00015311
![]() |
3',4-Dihydroxy-3,5'-dimethoxystilbene
|
![]() |
||||
C00015319
![]() |
Combretastatin A2
/ 3',4'-Dimethoxy-3'-hydroxy-4,5-methylenedioxystilbene |
CHEMBL47037
CHEMBL1642222 |
C061751
|
![]() |
||
C00015320
![]() |
3,4'-Dimethoxy-5-hydroxystilbene
|
CHEMBL315853
CHEMBL465542 |
![]() |
|||
C00015322
![]() |
3,4-Methylenedioxy-4'-methoxystilbene
|
![]() |
||||
C00015328
![]() |
Combretastatin A3
/ 3',5-Dihydroxy-3,4,4'-trimethoxystilbene |
CHEMBL464382
|
C440905
|
![]() |
||
C00015400
![]() |
3,5-Dimethoxystilbene
/ Pinosylvin dimethyl ether |
CHEMBL188181
CHEMBL2165238 |
6 / 7 / 3 |
![]() |
||
C00015429
![]() |
CRC 87-09
/ Combretastatin A4 / 3'-Hydroxy-3,4,4'5-tetramethoxystilbene |
CHEMBL67
CHEMBL36455 CHEMBL2142429 |
17 / 7 / 2 |
![]() |
||
C00015430
![]() |
3'-Hydroxy-3,4,5'-trimethoxystilbene
|
CHEMBL109860
|
2 / 0 / 0 |
![]() |
||
C00018988
![]() |
Resveratrol trimethyl ether
/ 3,5,4'-Trimethoxy-trans-stilbene |
CHEMBL296411
CHEMBL311636 |
25 / 16 / 22 |
![]() |
||
C00019230
![]() |
(E)-3,4'-Dimethoxystilbene
/ (E)-1-Methoxy-3-[2-(4-methoxyphenyl)ethenyl]-benzene |
CHEMBL215583
CHEMBL244727 |
![]() |
|||
C00019231
![]() |
(Z)-3,4'-Dimethoxystilbene
/ (Z)-1-Methoxy-3-[2-(4-methoxyphenyl)ethenyl]-benzene |
CHEMBL215583
CHEMBL244727 |
![]() |
|||
C00031008
![]() |
Phoyunbene A
|
CHEMBL2012416
|
![]() |
|||
C00031009
![]() |
Phoyunbene B
|
CHEMBL2012417
|
![]() |
|||
C00031010
![]() |
Phoyunbene C
|
CHEMBL2012418
|
![]() |
|||
C00031011
![]() |
Phoyunbene D
|
CHEMBL2012419
|
![]() |
|||
C00036552
![]() |
3-Methoxy-3',4'-methylenedioxy-cis-stilbene
|
![]() |
||||
C00036553
![]() |
3-Methoxy-3',4'-methylenedioxy-trans-stilbene
|
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q9BVA1 | Tubulin beta-2B chain | Structural | C00015429 C00018988 | 1 / 0 |
Q9BUF5 | Tubulin beta-6 chain | Structural | C00015429 C00018988 | 0 / 0 |
Q9BQE3 | Tubulin alpha-1C chain | Unclassified protein | C00015429 C00018988 | 0 / 0 |
Q9H4B7 | Tubulin beta-1 chain | Structural | C00015429 C00018988 | 1 / 0 |
Q6PEY2 | Tubulin alpha-3E chain | Unclassified protein | C00015429 C00018988 | 0 / 0 |
Q13885 | Tubulin beta-2A chain | Structural | C00015429 C00018988 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00002902 C00018988 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002902 C00015429 | 0 / 0 |
P68363 | Tubulin alpha-1B chain | Unclassified protein | C00015429 C00018988 | 0 / 0 |
Q13509 | Tubulin beta-3 chain | Structural | C00015429 C00018988 | 2 / 1 |
P68371 | Tubulin beta-4B chain | Structural | C00015429 C00018988 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00002902 C00015400 | 0 / 0 |
Q71U36 | Tubulin alpha-1A chain | Structural | C00015429 C00018988 | 1 / 1 |
P07437 | Tubulin beta chain | Structural | C00015429 C00018988 | 0 / 0 |
Q3ZCM7 | Tubulin beta-8 chain | Structural | C00015429 C00018988 | 0 / 0 |
P04350 | Tubulin beta-4A chain | Structural | C00015429 C00018988 | 2 / 0 |
P68366 | Tubulin alpha-4A chain | Structural | C00015429 C00018988 | 0 / 0 |
Q13748 | Tubulin alpha-3C/D chain | Structural | C00015429 C00018988 | 0 / 0 |
P11274 | Breakpoint cluster region protein | Bcr | C00002902 C00018988 | 1 / 2 |
P00519 | Tyrosine-protein kinase ABL1 | Abl | C00002902 C00018988 | 1 / 2 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002902 | 4 / 3 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00018988 | 0 / 0 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00002902 | 1 / 1 |
P03372 | Estrogen receptor | NR3A1 | C00018988 | 1 / 1 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00015430 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00015400 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00015400 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00018988 | 4 / 4 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00015400 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002902 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00002902 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002902 | 1 / 2 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00002902 | 2 / 2 |
P01106 | Myc proto-oncogene protein | Unclassified protein | C00018988 | 1 / 13 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00015400 | 0 / 0 |
Q04206 | Transcription factor p65 | Transcription Factor | C00015430 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00015400 | 7 / 3 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00002902 | 0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00002902 | 4 / 2 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002902 | 0 / 0 |
Q12778 | Forkhead box protein O1 | Unclassified protein | C00018988 | 1 / 1 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002902 | 0 / 0 |
P30874 | Somatostatin receptor type 2 | Somatostatin receptor | C00015204 | 0 / 0 |
P31391 | Somatostatin receptor type 4 | Somatostatin receptor | C00015204 | 0 / 0 |
P32745 | Somatostatin receptor type 3 | Somatostatin receptor | C00015204 | 0 / 0 |
P35346 | Somatostatin receptor type 5 | Somatostatin receptor | C00015204 | 0 / 0 |
P30872 | Somatostatin receptor type 1 | Somatostatin receptor | C00015204 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00002902 | 1 / 1 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00015429 | 0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00018988 | 0 / 0 |
P55789 | FAD-linked sulfhydryl oxidase ALR | Enzyme | C00002902 | 1 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00018988 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002902 | 1 / 1 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002902 | 0 / 3 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00002902
|
23600 | AMACR, AMACRD, CBAS4, RACE, RM | alpha-methylacyl-CoA racemase (EC:5.1.99.4) |
C00002902
|
1386 | ATF2, CRE-BP1, CREB2, HB16, TREB7 | activating transcription factor 2 (EC:2.3.1.48) |
C00002902
|
578 | BAK1, BAK, BAK-LIKE, BCL2L7, CDN1 | BCL2-antagonist/killer 1 |
C00002902
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002902
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002902
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00002902
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002902
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00002902
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002902
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002902
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00002902
|
2921 | CXCL3, CINC-2b, GRO3, GROg, MIP-2b, MIP2B, SCYB3 | chemokine (C-X-C motif) ligand 3 |
C00002902
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002902
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002902
|
1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00002902
|
56616 | DIABLO, DFNA64, SMAC | diablo, IAP-binding mitochondrial protein |
C00002902
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00002902
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00002902
|
2002 | ELK1 | ELK1, member of ETS oncogene family |
C00002902
|
2523 | FUT1, H, HH, HSC | fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) (EC:2.4.1.69) |
C00002902
|
9518 | GDF15, GDF-15, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB | growth differentiation factor 15 |
C00002902
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00002902
|
4670 | HNRNPM, CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1, hnRNP_M | heterogeneous nuclear ribonucleoprotein M |
C00002902
|
3313 | HSPA9, CSA, GRP-75, GRP75, HSPA9B, MOT, MOT2, MTHSP75, PBP74 | heat shock 70kDa protein 9 (mortalin) |
C00002902
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00002902
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00002902
|
3696 | ITGB8 | integrin, beta 8 |
C00002902
|
3717 | JAK2, JTK10, THCYT3 | Janus kinase 2 (EC:2.7.10.2) |
C00002902
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00002902
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002902
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00002902
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002902
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00002902
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00002902
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00002902
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00002902
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00002902
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00002902
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00002902
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00002902
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00002902
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00002902
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00002902
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002902
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00002902
|
6301 | SARS, SERRS, SERS | seryl-tRNA synthetase (EC:6.1.1.11) |
C00002902
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00002902
|
6667 | SP1 | Sp1 transcription factor |
C00002902
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00002902
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002902
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002902
|
9189 | ZBED1, ALTE, DREF, TRAMP, hDREF | zinc finger, BED-type containing 1 |
C00002902
|
118738 | ZNF488 | zinc finger protein 488 |
C00002902
|
OMIM | preferred title | UniProt |
---|---|---|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#113970 | Burkitt lymphoma; bl |
P01106
|
#614039 | Cortical dysplasia, complex, with other brain malformations 1; cdcbm1 |
Q13509
|
#128101 | Dystonia 4, torsion, autosomal dominant; dyt4 |
P04350
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600638 | Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement; cfeom3a |
Q13509
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#608232 | Leukemia, chronic myeloid; cml |
P00519
P11274 |
#612438 | Leukodystrophy, hypomyelinating, 6; hld6 |
P04350
|
#611603 | Lissencephaly 3; lis3 |
Q71U36
|
#613112 | Macrothrombocytopenia, autosomal dominant, tubb1-related |
Q9H4B7
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613076 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay |
P55789
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#610031 | Polymicrogyria, symmetric or asymmetric; pmgysa |
Q9BVA1
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#268220 | Rhabdomyosarcoma 2; rms2 |
Q12778
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
P00519
(related)
P00519 (marker) P01106 (related) P01106 (marker) P11274 (related) P11274 (marker) Q03164 (related) Q03164 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
P00519
(related)
P00519 (marker) P11274 (related) P11274 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
P01106
(related)
Q03164 (related) |
H00008 | Burkitt lymphoma |
P01106
(related)
P01106 (marker) |
H00010 | Multiple myeloma |
P01106
(related)
|
H00013 | Small cell lung cancer |
P01106
(related)
|
H00016 | Oral cancer |
P01106
(related)
|
H00025 | Penile cancer |
P01106
(related)
P35354 (related) |
H00027 | Ovarian cancer |
P01106
(related)
P38398 (related) |
H00028 | Choriocarcinoma |
P01106
(related)
|
H00031 | Breast cancer |
P01106
(related)
P38398 (related) |
H00036 | Osteosarcoma |
P01106
(related)
|
H00041 | Kaposi's sarcoma |
P01106
(related)
|
H00055 | Laryngeal cancer |
P01106
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P11511
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00037 | Alveolar rhabdomyosarcoma |
Q12778
(related)
Q12778 (marker) |
H00838 | Congenital fibrosis of the extraocular muscles (CFEOM) |
Q13509
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00268 | Lissencephaly (LIS) |
Q71U36
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D058739 | Aberrant Crypt Foci |
C00002902
|
D000236 | Adenoma |
C00002902
|
D001943 | Breast Neoplasms |
C00002902
|
D006528 | Carcinoma, Hepatocellular |
C00002902
|
D002471 | Cell Transformation, Neoplastic |
C00002902
|
D003110 | Colonic Neoplasms |
C00002902
|
D015179 | Colorectal Neoplasms |
C00002902
|
D007249 | Inflammation |
C00002902
|
D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
C00002902
|
D009361 | Neoplasm Invasiveness |
C00002902
|
D009362 | Neoplasm Metastasis |
C00002902
|
D012516 | Osteosarcoma |
C00002902
|
D010190 | Pancreatic Neoplasms |
C00002902
|
D010212 | Papilloma |
C00002902
|
D012878 | Skin Neoplasms |
C00002902
|